Top Markets
#1 Wibx Wibx +8.04%
#2 Wrapped Flare Wrapped Flare +4.46%
#3 Decred Decred +4.31%
#4 Humanity Humanity +4.26%
#5 Across Protocol Across Protocol +3.82%
#6 Pearl Pearl +3.51%
#7 aelf aelf +3.44%
#8 Audiera Audiera +2.66%
#9 MarsCoin MarsCoin +2.24%
#10 TRIA TRIA +2.06%
Coin of the day
Wibx Wibx
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rang in Aktien #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Aktienkurs
$0.089
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$15.36M
Veränderung (1 Tag)
50.59%
Veränderung (1 Jahr)
72.65%
Land
US
Handel Inhibitor Therapeutics, Inc. (INTI)

Kategorie

Healthcare
Preis INTI mit Marktkapitalisierung von B
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
INTI
$0.089
Marktkapitalisierung von Inhibitor Therapeutics, Inc.(INTI)
Marktkapitalisierung: $15.36M
Mit Stand August 2026 hat Inhibitor Therapeutics, Inc. eine Marktkapitalisierung von $15.36M. Das macht Inhibitor Therapeutics, Inc. laut unseren Daten zum 30838th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Inhibitor Therapeutics, Inc. von 2003 bis 2026
INTI im Vergleich zu den Top 5 der beliebtesten stocks
Preis für INTI Vermögenswert B Marktkapitalisierung von B Ergebnisse
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$30,749.66 $15.36M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.307T +34,550,085.07%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$26,369.80 $15.36M
Apple Inc. Apple Inc.
AAPL
$4.551T +29,628,891.27%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$24,072.99 $15.36M
Alphabet Inc. Alphabet Inc.
GOOG
$4.154T +27,048,208.47%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$20,794.30 $15.36M
Microsoft Corporation Microsoft Corporation
MSFT
$3.589T +23,364,277.97%
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.
$16,206.69 $15.36M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.797T +18,209,663.87%